Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children

Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children

Background. The optimum strategy for stopping treatment with drugs that have different half-lives in a combination regimen to minimize the risk of selecting drug-resistant viruses remains unknown. We evaluated drug concentrations in plasma, human immunodeficiency virus (HIV) load, and development of...

Full description

Saved in:
Bibliographic Details
Main Authors: Cressey T.R., Green H., Khoo S., Treluyer J.-M., Compagnucci A., Saidi Y., Lallemant M., Gibb D.M., Burger D.M.
Format: Article
Language:English
Published: 2014
Online Access:http://www.scopus.com/inward/record.url?eid=2-s2.0-43249121119&partnerID=40&md5=70cde227052f32d5d5b16fff84a6ff30
http://www.ncbi.nlm.nih.gov/pubmed/18419497
http://cmuir.cmu.ac.th/handle/6653943832/729
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Language: English

Internet

http://www.scopus.com/inward/record.url?eid=2-s2.0-43249121119&partnerID=40&md5=70cde227052f32d5d5b16fff84a6ff30
http://www.ncbi.nlm.nih.gov/pubmed/18419497
http://cmuir.cmu.ac.th/handle/6653943832/729

Similar Items